Next-level Dose Given in Trial of Stem Cell Therapy for Bradykinesia
IMAC Holdings has completed dosing the second group of patients in its Phase 1 clinical trial testing umbilical cord-derived…
Articles by Margarida Maia, PhD
Women Struggle More With Life Quality Than Men, Chinese Study Finds
Women with Parkinson’s disease in China appear to have a poorer quality of life than do men, a study…
DJ-1 Protein Loss Linked to Longer-lasting Immune Response
Loss of a protein called DJ-1, which is linked to the development of early-onset Parkinson’s disease, may also mean…
2022 Cure One, Cure Many $3M Award Goes to Mayo Clinic Researchers
Winners of the 2022 edition of the $3 million Cure One, Cure Many Award for the early diagnosis of…
ENT-01 Targets Protein in Gut to Ease Patients’ Constipation, Trial Reports
A short course of ENT-01, Enterin’s investigational therapy for Parkinson’s disease, appears to restore the function of nerve…
Funding Boost From MJFF Advances Lysosome-targeting Therapies
Caraway Therapeutics was awarded a new research grant from the Michael J. Fox Foundation (MJFF) to further work on…
Planned Phase 3 Trials of Oral Buntanetap to Span Disease Stages
The U.S. Food and Drug Administration (FDA) has given positive feedback to Annovis Bio’s plans to start two Phase 3…
Dosing Starts in Canada in Trial of DA01 for Advanced Parkinson’s
A first patient in Canada has been dosed in a Phase 1 clinical trial of DA01, a cell-based investigational therapy…
Scientists Win $1.2M Grant to Study How Stress Can Worsen Parkinson’s
A team of scientists at the University of Cincinnati, in Ohio, has received a grant worth $1.2 million from the…
Companies Using AI to Identify Small Molecules to Treat Parkinson’s
Iktos is working with Astrogen to use artificial intelligence (AI) to identify small molecules as candidates for the…